• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL DELTAXTRASOFT COIL; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL DELTAXTRASOFT COIL; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Catalog Number DLX100306
Device Problems Premature Activation (1484); Stretched (1601)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/02/2017
Event Type  malfunction  
Manufacturer Narrative
Concomitant medical products: enterprise2 4mm x 30mm stent, sl10 coiling catheter in place micrusframe 5mm x 9.7cm microcoil, galaxy g3 4mm x 8cm coil, galaxy 4mm x 6cm coil.Mfg name: codman & shurtleff, inc.Dba depuy synthes products, inc.The device was returned for analysis; however, the analysis has not yet been completed.Additional information will be submitted within 30 days of receipt.
 
Event Description
As reported via a health professional, a deltaxsft (dlx100306/ s14198) prematurely detached while being positioned in the 5.5mm carotid terminus aneurysm.An enterprise2 4mm x 30mm stent have been placed successfully and the physician had jailed the sl10 coiling catheter in place.The aneurysm successfully framed with a micrusframe 5mm x 9.7cm microcoil.This was followed by a galaxy g3 4mm x 8cm coil and then an additional galaxy 4mm x 6cm coil.The deltaxsft 3mm x 6cm coil (complaint coil) was chosen for the next coil, but it unintentionally detached during placement into the aneurysm.Approximately 2/3 of the coil was placed in the aneurysm when the physician began to reposition the coil.After a small amount of movement pulling the coil out and advancing it, the physician decided he did not have control of the coil and felt it had detached.The physician confirmed he could not remove the coil.The coil detached in the microcatheter without activating the enpower cable.It appeared to detach with minimal manipulation by the physician.He then successfully pushed the remaining approx.1.5cm of coil into the aneurysm, but it was in a position that was not completely secured with the rest of the coil mass.Ultimately, he felt the coil was well protected from the parent artery by the stent, so the procedure was concluded successfully.After the case, the physician remarked that he felt some resistance when repositioning the coil, but did not feel he pulled the coil with considerable force that would detach the coil.The patient was doing well at conclusion of the procedure.It was reported that the device would be returned for analysis.
 
Manufacturer Narrative
As reported via a health professional, a deltaxsft (dlx100306/s14198) prematurely detached while being positioned in the 5.5mm carotid terminus aneurysm.An enterprise2 4mm x 30mm stent have been placed successfully and the physician had jailed the sl10 coiling catheter in place.The aneurysm successfully framed with a micrusframe 5mm x 9.7cm microcoil.This was followed by a galaxy g3 4mm x 8cm coil and then an additional galaxy 4mm x 6cm coil.The deltaxsft 3mm x 6cm coil (complaint coil) was chosen for the next coil, but it unintentionally detached during placement into the aneurysm.Approximately 2/3 of the coil was placed in the aneurysm when the physician began to reposition the coil.After a small amount of movement pulling the coil out and advancing it, the physician decided he did not have control of the coil and felt it had detached.The physician confirmed he could not remove the coil.The coil detached in the microcatheter without activating the enpower cable.It appeared to detach with minimal manipulation by the physician.He then successfully pushed the remaining approx.1.5cm of coil into the aneurysm, but it was in a position that was not completely secured with the rest of the coil mass.Ultimately, he felt the coil was well protected from the parent artery by the stent so the procedure was concluded successfully.After the case, the physician remarked that he felt some resistance when repositioning the coil, but did not feel he pulled the coil with considerable force that would detach the coil.The patient was doing well at conclusion of the procedure.The device was returned with its inner pouch.Labeling on the inner pouch matches the product documented in the complaint.The device was fully unsheathed.The embolic coil was not attached and was not returned.There were bends in the device positioning unit (dpu) core wire approximately 10 cm, 81 cm, 100 cm, 106 cm, and 139 cm from the proximal end.The detachment fiber was broken and not melted.The resistance heating (rh) coil has not received heat.The resheathing tool was undamaged.A review of manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection processes related to the reported complaint.The complaint that the coil detached prematurely was confirmed.The embolic coil was not attached, the rh coil did not receive heat, and the detachment fiber was broken and not melted.The bends in the dpu core wire indicate that excessive force was applied to the device, possibly during the reported relocation of the embolic coil.The physician reported that some resistance was felt when repositioning the coil.Application of force to overcome resistance could cause the observed damage to the dpu core wire and the detachment fiber.100% of devices are inspected for condition of the detachment fiber during qc final inspection, so it is unlikely that the detachment fiber was broken when the device left the manufacturing facility.Since in the reported sequence of events the physician was able to retract and advance the embolic coil during the repositioning activity, it is most likely that the detachment fiber broke during the procedure while the embolic coil was being repositioned, and as a result of application of excessive force.There is no current safety signal identified related to the reported event based on review of complaint history for the device.Since there was no evidence to suggest the event was related to a manufacturing issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTAXTRASOFT COIL
Type of Device
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
rue girardet 29
le locle jura
SZ 
Manufacturer Contact
joaquin kurz
47709 freemont blvd
freemont, CA 94538
9497899383
MDR Report Key6978953
MDR Text Key90842461
Report Number3013875781-2017-00017
Device Sequence Number1
Product Code HCG
UDI-Device Identifier10886704077350
UDI-Public(01)10886704077350(17)200630(10)S14198
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150319
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 10/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue NumberDLX100306
Device Lot NumberS14198
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/22/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/27/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-